STAT

Health officials are hunting for the culprit behind vaping-related illnesses. Here are five questions about the outbreak

What’s causing it? And do all the cases represent the same illness? Those and other big, looming questions about the recent spate of vaping-related illnesses and deaths.

Health officials are still scrambling to pinpoint the cause of an outbreak of lung illnesses in people who vape — and the wide geographic spread of cases and the vast vape market are making that investigation more challenging.

There have been 380 confirmed and probable cases of the severe breathing illnesses among people who vape, according to the Centers for Disease Control and Prevention. Six people have died due to the illnesses, which have cropped up in 36 states and the U.S. Virgin Islands.

Those numbers, released late last week, marked a decrease from the 450 cases reported the week prior, when officials were also counting “possible cases” that were still under investigation in their tallies.The CDC says the number of cases is likely to climb as they classify more cases, a thorough process that involves reviewing a patient’s medical records and interviewing their health care providers.

But health officials still haven’t identified why vapers —  the majority of cases are

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks